发明名称 COMPOUND
摘要 The present invention relates to a compound of formula (I): Wherein R1 is a substituted or unsubstituted aromatic hetero- or homocyclic or a substituted or unsubstituted alicyclic hetero- or homocyclic group; R2 is an alkyl group with 1 to 18 carbon atoms or a substituted or unsubstituted cycloalkyl or aryl group; R3 is a substituted or unsubstituted aromatic hetero- or homocyclic or a substituted or unsubstituted alicyclic hetero- or homocyclic group; L is a single bond, an alkyl group having 1 to 6 carbon atoms, NHCO, O, S, NHCONH or NHCOO; X, Y and Z are independently 0, N, NH, S or CH; W is a single bond or an alkyl group having from 1 to 6 carbon atoms; or a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate of said compound or salt. I
申请公布号 CA2784744(A1) 申请公布日期 2011.07.14
申请号 CA20102784744 申请日期 2010.12.16
申请人 NEUROPORE THERAPIES, INC. 发明人 MASLIAH, ELIEZER;ROCKENSTEIN, EDWARD M.;WRASIDLO, WOLFGANG;TSIGELNY, IGOR FLINT
分类号 C07D403/12;A61K31/404;A61K31/4184;A61K31/4196;A61K31/422;A61K31/427;A61K31/519;A61K31/52;A61P25/16;A61P25/28;C07D413/12;C07D417/12;C07D473/00;C07D487/04 主分类号 C07D403/12
代理机构 代理人
主权项
地址